Richard Harris

The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer's illness.

Medical researchers have high hopes that the kind of treatment the president received could end up being an important element in the fight against the pandemic. But clinical trials continue.

President Trump continues to tout an experimental treatment he received for COVID-19. NPR discusses if the drug is safe and whether there is enough of it to distribute across the U.S.

NPR discusses the latest on President Trump's health, his treatment for COVID-19 and his misleading statements on social media downplaying the lethality of the illness.

Lots of questions remain about President Trump's condition. NPR discusses his health and medical treatment and what would be the best safety protocols for the White House to follow.

President Trump is hospitalized and is being treated with experimental therapies less than a month from Election Day. There was a briefing on his condition Sunday.

One thing that has improved a lot over the course of the pandemic is treatment of seriously ill COVID-19 patients in intensive care units. Here's one man's success story.

Drugs are being tested that could reduce symptoms and save lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent as a successful vaccine.

Most drugs don't actually cure diseases. They can help ease symptoms and up the odds of survival. This will likely be true for COVID-19 drugs. A true cure would likely take years to develop.

Multiple studies now confirm earlier research: Dexamethasone and hydrocortisone, drugs that reduce an immune system's overreaction, can help reduce deaths of hospitalized COVID-19 patients.

New studies strongly support the use of corticosteroids to treat COVID-19. These drugs are inexpensive and widely available. Early controversy over their effectiveness may now largely be settled.

Health officials have confirmed 6 million cases of the coronavirus in the U.S., though the actual number might be far higher.

The Food and Drug Administration and the Centers for Disease Control and Prevention are facing a credibility crisis after botched communication efforts and perceptions of political interference.

The agency now says contacts of people with COVID-19 don't necessarily need to get tested. Public health experts say less testing of potential carriers could lead to more spread of the disease.

The Centers for Disease Control and Prevention has changed its coronavirus testing guidelines, raising questions about whether the move was done to reduce testing.

The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.

NPR takes a look at the effectiveness of convalescent plasma in treating COVID-19 and discusses a patient in Hong Kong who got infected with the coronavirus twice.

Masks are a key weapon against COVID-19, but how do you pick one? We have an update on the mask news of the week.

Russia said it has approved a coronavirus vaccine, even though skeptics say it has not been tested for safety and effectiveness. Vaccine experts say it is a potentially dangerous political stunt.

Scientists are now checking to see if purified blood serum from people who have recovered from COVID-19 might be more than a useful treatment. Perhaps it's a way to prevent disease in someone else.